Home / Safety / Le Chat (Mistral) for the pharmaceutical industry

Mistral AI

How safe is Le Chat (Mistral) for the pharmaceutical industry?

GDPR profileOur summary of what the provider itself publishes about your data: EU hosting possible, no training on your data for business use, and self-hostable. Caution is given to a model with a documented issue, such as an investigation by a regulator. How we measure for the pharmaceutical industryStrong

Le Chat (Mistral) has a strong published GDPR profile and, with the right business settings, is well suited to use in the pharmaceutical industry.

Where does Le Chat (Mistral) stand in the pharmaceutical industry?

Shared spot 1 of 25 options for the pharmaceutical industry (professional tools and general assistants) on GDPR profile. 5 options, like Le Chat (Mistral), have a strong profile. Each tile is an option we track for this field; click for the check.

Strong5
Good3
Limited7
Unknown3
Caution7

Stronger or equally strong in the pharmaceutical industry

Latest developments

30 October 2026Mistral Large 4: weights freely available under an open-weight licence

The weights of Mistral Large 4 are available on Hugging Face under the Mistral Ecosystem Open-Weight License, a derivative of MIT with restrictions for model-as-a-service. This means you can host the flagship model yourself within the EU or on your own servers, so personal data does not go to an external provider. If you offer the model as a service to third parties, check the licence terms first. source

20 October 2026Voxtral 3: speech models via EU-hosted API or your own servers

Mistral released Voxtral 3 (transcription, speech and an API for voice agents). The models are available via Mistral's EU-hosted API or can be run on your own infrastructure, which simplifies the GDPR assessment for recorded conversations. source

6 October 2026Mistral Large 4: trained in Europe, weights end of October

Mistral Large 4 (1 trillion parameters, 49 billion active) is available as a preview via the API. The model was trained in Mistral's own European data centres; according to Mistral, the weights will be released at the end of October so you can host it yourself. The licence has not yet been announced. source

Questions

How safe is Le Chat (Mistral) for the pharmaceutical industry?
Le Chat (Mistral) has a strong published GDPR profile and, with the right business settings, is well suited to use in the pharmaceutical industry. EU options, no training on your data and/or self-hostable.
Does Le Chat (Mistral) train on my data?
Data is held in the EU by default (Paris cloud, plus EU regions via Bedrock/Azure/Vertex). Open models run entirely in your own environment. Pro/Team/Enterprise and API do not train on your data.
What should I look out for with AI in the pharmaceutical industry?
This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.

Source documents

Everything about Le Chat (Mistral) Best AI for the pharmaceutical industry

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 22 October 2026 · How we check

Every Friday: what changed in AI for the pharmaceutical industry

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.